A sustained-release microcarrier effectively prolongs and enhances the antibacterial activity of lysozyme

J Environ Sci (China). 2023 Jul:129:128-138. doi: 10.1016/j.jes.2022.09.001. Epub 2022 Sep 13.

Abstract

Bacterial infections have become a great threat to public health in recent years. A primary lysozyme is a natural antimicrobial protein; however, its widespread application is limited by its instability. Here, we present a poly (N-isopropylacrylamide) hydrogel inverse opal particle (PHIOP) as a microcarrier of lysozyme to prolong and enhance the efficiency against bacteria. This PHIOP-based lysozyme (PHIOP-Lys) formulation is temperature-responsive and exhibits long-term sustained release of lysozyme for up to 16 days. It shows a potent antibacterial effect toward both Escherichia coli and Staphylococcus aureus, which is even higher than that of free lysozyme in solution at the same concentration. PHIOPs-Lys were demonstrated to effectively inhibit bacterial infections and enhance wound healing in a full-thickness skin wound rat model. This study provides a novel pathway for prolonging the enzymatic activity and antibacterial effects of lysozyme.

Keywords: Bacterial infection; Inverse opal particle; Lysozyme; Temperature-responsive; Wound healing.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents*
  • Delayed-Action Preparations / pharmacology
  • Escherichia coli
  • Muramidase* / pharmacology
  • Rats

Substances

  • Muramidase
  • Delayed-Action Preparations
  • Anti-Bacterial Agents
  • Anti-Infective Agents